Frontiers in Cell and Developmental Biology (Jan 2022)

The Role and Therapeutic Value of Syndecan-1 in Cancer Metastasis and Drug Resistance

  • Sen Guo,
  • XinYi Wu,
  • Ting Lei,
  • Rui Zhong,
  • YiRan Wang,
  • Liang Zhang,
  • QingYi Zhao,
  • Yan Huang,
  • Yin Shi,
  • Yin Shi,
  • Luyi Wu

DOI
https://doi.org/10.3389/fcell.2021.784983
Journal volume & issue
Vol. 9

Abstract

Read online

Metastasis and relapse are major causes of cancer-related fatalities. The elucidation of relevant pathomechanisms and adoption of appropriate countermeasures are thus crucial for the development of clinical strategies that inhibit malignancy progression as well as metastasis. An integral component of the extracellular matrix, the type 1 transmembrane glycoprotein syndecan-1 (SDC-1) binds cytokines and growth factors involved in tumor microenvironment modulation. Alterations in its localization have been implicated in both cancer metastasis and drug resistance. In this review, available data regarding the structural characteristics, shedding process, and nuclear translocation of SDC-1 are detailed with the aim of highlighting strategies directly targeting SDC-1 as well as SDC-1-mediated carcinogenesis.

Keywords